辅酶Q10和血脑屏障:一个概述
David Mantle1, Iain Hargreaves2
1Pharma Nord (UK) Ltd., Morpeth NE61 2DB, UK.
Journal of clinical medicine
|April 26, 2025
概括
辅酶Q10 (CoQ10) 缺乏与神经系统疾病有关. 这篇评论检查了CoQ10是否可以穿越血脑屏障,这可能解释了为什么尽管动物研究成功,但补充剂在人体试验中失败.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 线粒体功能障碍与帕金森病,阿尔茨海默病和ALS等神经退行性疾病有关.
- 辅酶Q10 (CoQ10) 对线粒体功能至关重要,在这些疾病中发现其缺乏.
- 辅酶Q10补充在动物模型中表现有希望,但在PD,AD和ALS的人类临床试验中产生令人失望的结果.
研究的目的:
- 审查有关CoQ10在人类中穿越血脑屏障 (BBB) 的现有文献.
- 调查CoQ10补充剂临床前和临床结果之间的差异的潜在原因.
主要方法:
- 对同行评审的科学文献进行系统审查.
- 对研究研究BBB. CoQ10运输的研究分析.
主要成果:
- 关于 CoQ10 透到人类 BBB 的证据仍然不确定.
- 结果的差异可能源于 CoQ10 治疗性大脑度的挑战.
结论:
- 需要进一步的研究来澄清CoQ10在人类中的BBB透性.
- 了解CoQ10的大脑吸收对于评估其在神经系统疾病中的治疗潜力至关重要.
相关概念视频
The Blood-brain Barrier
46.3K
Overview
46.3K
Physiological Barriers
3.2K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.2K
Biopharmaceutics and Pharmacokinetics: Overview
1.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.7K
Factors Affecting Drug Distribution: Physiological Barriers
131
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
131
Bioavailability: Overview
2.5K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.5K
Pharmacodynamics: Overview and Principles
890
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
890


